相关实验视频

Updated: Jul 14, 2026

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

外体非编码RNA在心脏重塑中的研究进展

Yang Liu¹, Xing Lyu², Shengyu Tan^1,3

¹Department of Geriatrics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.

International journal of medical sciences

|October 4, 2023

概括

外体,细胞释放的微小囊泡,是细胞通信的关键. 本综述探讨了外体非编码RNA如何影响心脏病及其临床潜力.

科学领域:

心血管生物学心血管生物学
细胞生物学细胞生物学
分子医学是分子医学.

背景情况:

外体是细胞分泌的纳米级囊泡 (50-200 nm),调解细胞间通信.
外体非编码RNA与病态心脏重塑过程有关.
这些包括心肌细胞缩,亡和心脏纤维化.

研究的目的:

审查外体的起源和功能.
阐明外体非编码RNA在病态心脏重塑中的作用.
讨论它们在心血管疾病中的临床应用的理论基础.

主要方法:

在心脏重塑中对外体和非编码RNA的文献综述.
对外体生物发生和负载的当前研究进行分析.
综合与心脏病理学中的非编码RNA功能相关的发现.

主要成果:

外基因组促进心脏细胞之间非编码RNA的转移.
特定的外体非编码RNA与心肌细胞缩,亡和纤维化有关.
这些发现突出了外体的潜力作为生物标志物和治疗点.

结论:

外体非编码RNA是病态心脏重塑的关键调解者.
了解它们的作用为新的心血管疾病诊断和治疗提供了基础.
需要进一步的研究来将这些发现转化为临床实践.

更多相关视频

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Published on: October 26, 2020

Author Spotlight: Enhancing Coronary Artery Revascularization

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

相关概念视频

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...